Major and minor complications within 30 days (TAT vs DAT group)
| TAT group (n=110) | DAT group (n=73) | P-values | OR | 95% CI | |
| Major complications, n (%) | 1 (0.9%) | 6 (8.2%) | 0.017 | 0.102 | 0.012 to 0.870 |
| TIA | 1 (0.9%) | 3 (4.1%) | 0.303 | 0.214 | 0.022 to 2.099 |
| ischemic stroke | 0 (0%) | 3 (4.1%) | 0.062 | 1.043 | 0.994 to 1.094 |
| Stent thrombosis | 0 (0%) | 0 (0%) | – | – | – |
| Intracranial bleeding | 0 (0%) | 0 (0%) | – | – | – |
| Extracranial bleeding | 0 (0%) | 0 (0%) | – | – | – |
| Minor complications, n (%) | 1 (0.9%) | 1 (1.4%) | >0.999 | 0.661 | 0.041 to 10.73 |
DAT, dual antiplatelet therapy; TAT, triple antiplatelet therapy; TIA, transient ischemic attack.